GlassScriptPhysician profile
Mark J Charlamb
NPI 1760480982
$1,564.03
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,295 · 2020: $65.45 · 2022: $66.70 · 2023: $24.30 · 2024: $112.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $137.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $136.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $220.03 | 2019 | |
| Janssen Pharmaceuticals, INC | $197.49 | 2019 | |
| Sanofi-Aventis U.S. LLC | $172.02 | 2019-2023 | |
| Abiomed | $120.73 | 2019-2024 | Impella |
| Boehringer Ingelheim Pharmaceuticals, INC. | $105.40 | 2019 | |
| Gilead Sciences, INC. | $87.91 | 2019 | |
| Novartis Pharmaceuticals Corporation | $80.16 | 2019 | |
| Amarin Pharma, INC. | $73.68 | 2019 | |
| Lantheus Medical Imaging, INC. | $70.45 | 2019 | |
| Medtronic, INC. | $66.75 | 2024 | Linq II |
| Biosense Webster, INC. | $65.45 | 2020 | |
| Regeneron Healthcare Solutions, INC. | $65.06 | 2019 | |
| Baxter Healthcare | $45.00 | 2022 | |
| Edwards Lifesciences Corporation | $33.41 | 2019 | |
| Vifor Pharma, INC. | $24.60 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $24.41 | 2019 | |
| Pfizer INC. | $23.04 | 2019 | |
| Merck Sharp & Dohme LLC | $21.70 | 2022 | |
| Astellas Pharma US INC | $20.25 | 2019 | |
| Actelion Pharmaceuticals US, INC. | $18.28 | 2019 | |
| Abbott Laboratories | $15.03 | 2019 | |
| Smith+Nephew, INC. | $13.18 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Charlamb listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.